Acarix AB (publ) (STO:ACARIX)

Market Cap	343.17M
Revenue (ttm)	5.56M
Net Income (ttm)	-61.57M
Shares Out	1.12B
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	331,276
Average Volume	1,372,580
Open	0.3105
Previous Close	0.3055
Day's Range	0.3000 - 0.3105
52-Week Range	0.1688 - 0.4710
Beta	1.06
RSI	46.70
Earnings Date	Nov 6, 2025

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACARIX

Financial Performance

In 2024, Acarix AB's revenue was 6.20 million, a decrease of -0.62% compared to the previous year's 6.24 million. Losses were -66.19 million, -14.97% less than in 2023.